戻る Agenda
The Regulatory Role in EU Public-Private Partnerships (PPPs)
Session Chair(s)
João Duarte, MPHARM, MSC
Vice President, Head of Global Regulatory Affairs Excellence
Ipsen, France
This forum will discuss how regulatory contribution to EU public-private partnerships like the Innovative Medicines Initiative (IMI) was critical for its outcomes and for the advancement of EU regulatory science. Panelists will reflect on past and current achievements, while looking beyond 2019 and towards the new Framework Programme 9 (Horizon Europe), reflecting on possible partnerships that can bring added value to drug development and healthcare in the EU and globally.
Speaker(s)
Panel Discussion
Magda Chlebus, MA
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
Executive Director, Science Policy & Regulatory Affairs
Panel Discussion
Solange Corriol-Rohou, DrMed, MD, PHD
SCR Consulting, France
Panel Discussion
David Haerry
EATG, Switzerland
Patient Advocate